Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000315066-01-000048
Filing Date
2001-02-09
Accepted
2001-02-09 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G - 02-10-01 - OSI PHARMACEUTICALS 0001.txt SC 13G/A 13035
  Complete submission text file 0000315066-01-000048.txt   15125
Mailing Address 82 DEVONSHIRE STREET BOSTON MA 02109
Business Address 82 DEVONSHIRE ST BOSTON MA 02109 6175706339
FMR CORP (Filed by) CIK: 0000315066 (see all company filings)

EIN.: 161144965 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 0000

Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
OSI PHARMACEUTICALS INC (Subject) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G/A | Act: 34 | File No.: 005-37954 | Film No.: 1530465
SIC: 2835 In Vitro & In Vivo Diagnostic Substances